z-logo
open-access-imgOpen Access
Sequence and structure of the human 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase heart isoform gene ( PFKFB2 )
Author(s) -
HeineSuñer Damián,
DíazGuillén Miguel Angel,
Lange Alex J.,
Rodríguez de Córdoba Santiago
Publication year - 1998
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1046/j.1432-1327.1998.2540103.x
Subject(s) - gene isoform , phosphofructokinase 2 , biology , exon , gene , complementary dna , intron , isozyme , biochemistry , consensus sequence , microbiology and biotechnology , sequence analysis , peptide sequence , alternative splicing , map3k7 , enzyme , cell cycle , cyclin dependent kinase 2
6‐Phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase (PFK‐2/FBPase‐2) is a bifunctional enzyme that catalyzes the synthesis and degradation of Fru‐2,6‐ P 2 , a key regulator of glycolysis. In mammals, several genes have been found to code for different PFK‐2/FBPase‐2 isoforms that differ in tissue distribution and enzymatic activities. In the present study, we report the characterization of the PFK‐2/FBPase‐2 heart isoform gene in humans ( PFKFB2 ), including a full analysis of repetitive sequences and potential transcription binding sites. The genomic sequence of the PFKFB2 gene spans 22 485 bp and contains 15 exons. Heart cDNA analysis shows that PFKFB2 codes for a protein of 505 amino acids with a deduced molecular mass of 58 849 Da. Comparison of the human PFKFB2 gene to the homologous genes in rat and ox outlines a significant conservation of the intron‐exon structure, sequence of 5′ and 3′ flanking regions, and simple sequence repetitive element positions. Most important, the human heart PFK‐2/FBPase‐2 protein was found to retain all the important regulatory sites, as well as the catalytic and substrate binding sites identified in the rat and bovine heart isoforms, suggesting that the human enzyme is regulated in a manner similar to that observed in these organisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here